Biolife solutions to report second quarter 2025 financial results and business update on august 7, 2025

Bothell, wash. , july 24, 2025 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("cgt") market, today announced the company's second quarter 2025 financial results will be released after market close on thursday, august 7, 2025.

BLFS Ratings Summary

BLFS Quant Ranking